The STIMULATE study will assess how patients with Long Covid progress and recover, explore innovative treatment options and investigates health inequalities
Dr Michael Wangler, Assistant Professor at Molecular and Human Genetics Baylor College of Medicine and Katie Sacra, Director of Family Programs, Global Foundation for Peroxisomal Disorders, mother of TJ, discusses the impact of the COVID-19 pandemic on families with rare disease - especially peroxisomal disorders.
Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Nicola Hemmings, workplace scientist at Koa Health, and Dr Claire Vowell, lead psychologist, discuss how mental health conditions exist across a continuum and address what organisations can do to better support those who do not have a mental health diagnosis.
The UK will no longer run the REACT study, an 150,000 person analysis of real-time infection, or fund the SIREN study - which monitors COVID levels in healthcare workers.
Jeff Wyrtzen, Chief Marketing & Business Development Officer at Brainomix, explores a study proving that e-Stroke software improves stroke treatment rates
The rates of stillbirths in Black and South Asian communities are still double those of the rest of the population, despite an overall downward trend across the UK.
